ข้ามไปยังเนื้อหาหลัก

ENGLISH · EVIDENCE OVERVIEW

RAD140 / Vosilasarm
evidence profile

Investigational selective androgen receptor modulator. This page provides a concise English boundary and links back to the complete source-rich Thai profile.

RAD140 / Vosilasarm: conceptual scientific illustration for Clinical / Endocrine Pharmacology
VISUAL GUIDE · RAD140 / Vosilasarm

Clinical / Endocrine Pharmacology

Conceptual educational illustration. It is not a treatment outcome and does not establish efficacy or safety.

QUICK ANSWER · AEO / GEO

RAD140, vosilasarm and the online term Testolone refer to an investigational SARM candidate; Testolone is not testosterone. A first-in-human study enrolled 22 postmenopausal women with advanced breast cancer and reported target engagement, preliminary antitumour activity and frequent liver-test abnormalities. This does not establish bodybuilding or performance benefit, safety in healthy users or approval. FDA identifies marketed RAD-140 products as unapproved drugs, and WADA prohibits RAD140 at all times.

01

ENTITY FACTS

What should readers identify first?

MOLECULERAD140 / Vosilasarm
PHARMACOLOGYInvestigational selective androgen receptor modulator
PRIMECORE CLASSB
EVIDENCE GRADEC
RESEARCH TOPICClinical / Endocrine Pharmacology
LAST REVIEWED2026-09-01
02

EVIDENCE BOUNDARY

What this overview does not establish

  • An evidence grade does not rank this molecule against another treatment.
  • A molecule name does not establish the identity, purity or regulatory status of a product.
  • Animal, cell or biomarker findings do not automatically establish human clinical benefit.
  • Approval in one country or indication does not transfer globally.
03

FAQ · ANSWER ENGINE

Frequently asked questions

What is RAD140 / Vosilasarm?

RAD140 / Vosilasarm is described pharmacologically as Investigational selective androgen receptor modulator. RAD140, vosilasarm and the online term Testolone refer to an investigational SARM candidate; Testolone is not testosterone. A first-in-human study enrolled 22 postmenopausal women with advanced breast cancer and reported target engagement, preliminary antitumour activity and frequent liver-test abnormalities. This does not establish bodybuilding or performance benefit, safety in healthy users or approval. FDA identifies marketed RAD-140 products as unapproved drugs, and WADA prohibits RAD140 at all times.

Does RAD140 / Vosilasarm have strong evidence?

PrimeCoreBio records Evidence Grade C. This grade describes evidence strength, not comparative effectiveness or suitability for an individual.

Is RAD140 / Vosilasarm approved everywhere?

No global conclusion should be inferred. PrimeCore Class B must be read with the exact product, country and indication on the source-rich profile.

Medical Disclaimer

Educational information only. This page does not provide diagnosis, treatment, prescribing, dosage, injection instructions or individual medical advice.

LINE · สอบถามข้อมูลทั่วไปติดต่อฝ่ายข้อมูลทั่วไปLINE · GENERAL SUPPORTGeneral enquiries@primecoreสำหรับข้อมูลทั่วไปเท่านั้น · ไม่มีบริการด้านการขายหรือคำแนะนำทางการแพทย์General information only · No sales or medical advice